Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Imatinib-Induced Tremor in a Patient with Chronic Myeloid Leukemia in Chronic Phase

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case Reports in Oncology 2019-09, Vol.12 (3), p.913-917
Hauptverfasser: Obeidat, Khaldun, Alsaud, Arwa, Ashour, Amr, Azrieh, Bahjat, Abu-Tineh, Mohammad, Mohamed, Shehab Fareed, Yassin, Mohamed A.
Format: Artikel
Sprache:eng
Schlagworte:
Blood
Case Report
Case reports
Case studies
Causes of
Chromosomes
Chronic myeloid leukemia
Complications and side effects
Drug therapy
Hematology
imatinib
Imatinib mesylate
Inhibitor drugs
Leukemia
Medical education
Medical research
National libraries
Oncology
Patients
Pediatrics
Response rates
side effects
Targeted cancer therapy
Tremor
tyrosine kinases
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by three phases: chronic, accelerated, and blast phase. However; first- and second-generation tyrosine kinase inhibitors are used for the treatment of CML with common and uncommon adverse events. Here, we report a 24-year-old male with CML in chronic phase started on imatinib as upfront medication who developed tremor and recovered spontenously after 3 years.
ISSN:1662-6575
1662-6575
DOI:10.1159/000504937